Trial
NCT03950037
SANCC: Clinical Trial Early Intervention
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Oregon Health and Science University
Collaborators
Universidad Peruana Cayetano Heredia; National Institute of Neurological Disorders and Stroke (NINDS)
Condition
Subarachnoid Neurocysticercosis
Intervention
Albendazole
Why stopped
Unable to complete due to SARS-CoV-2 pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-12